The Beauty Health Company - Class A Common Stock (SKIN)

Shareholders of BeautyHealth would probably like to forget the past six months even happened. The stock dropped 46.5% and now trades at $0.89. This may have investors wondering how to approach the situation.

A number of stocks jumped in the afternoon session after investor sentiment improved on renewed optimism that the US-China trade conflict might be nearing a resolution. According to reports, Treasury Secretary Scott Bessent reinforced this positive outlook by describing the trade war as "unsustainable," and emphasized that a potential agreement between the two economic powers "was possible." His comments signaled to markets that both sides might be motivated to seek common ground, raising expectations for reduced tariffs and more stability across markets.

The end of the earnings season is always a good time to take a step back and see who shined (and who not so much). Let’s take a look at how personal care stocks fared in Q4, starting with Edgewell Personal Care (NYSE:EPC).

Quarterly earnings results are a good time to check in on a company’s progress, especially compared to its peers in the same sector. Today we are looking at Inter Parfums (NASDAQ:IPAR) and the best and worst performers in the personal care industry.

Many small-cap stocks have limited Wall Street coverage, giving savvy investors the chance to act before everyone else catches on. But the flip side is that these businesses have increased downside risk because they lack the scale and staying power of their larger competitors.

As the craze of earnings season draws to a close, here’s a look back at some of the most exciting (and some less so) results from Q4. Today, we are looking at personal care stocks, starting with USANA (NYSE:USNA).

As the Q4 earnings season wraps, let’s dig into this quarter’s best and worst performers in the personal care industry, including BeautyHealth (NASDAQ:SKIN) and its peers.

Shares of skincare company BeautyHealth (NASDAQ:SKIN) fell 11.7% in the afternoon session after the company reported underwhelming fourth-quarter results: its full-year revenue guidance missed significantly, disappointing investors. What stood out was BeautyHealth's sharp improvement in profitability, with adjusted EBITDA jumping nearly threefold year-over-year to $9 million. Despite this, sales declined 14% compared to the previous year, mainly due to a slowdown in delivery system sales, particularly in the Asia-Pacific region. Overall, this quarter was mixed but still had some key positives. The market seemed to focus on the negatives, and the stock traded down.

Skincare company BeautyHealth (NASDAQ:SKIN) reported Q4 CY2024 results exceeding the market’s revenue expectations, but sales fell by 13.7% year on year to $83.5 million. On the other hand, next quarter’s revenue guidance of $63.5 million was less impressive, coming in 16.6% below analysts’ estimates. Its GAAP loss of $0.08 per share was 30% above analysts’ consensus estimates.

Skincare company BeautyHealth (NASDAQ:SKIN) will be announcing earnings results tomorrow afternoon. Here’s what you need to know.

Over the past six months, BeautyHealth’s stock price fell to $1.49. Shareholders have lost 18.1% of their capital, which is disappointing considering the S&P 500 has climbed by 10.4%. This might have investors contemplating their next move.

The end of an earnings season can be a great time to discover new stocks and assess how companies are handling the current business environment. Let’s take a look at how Inter Parfums (NASDAQ:IPAR) and the rest of the personal care stocks fared in Q3.

The end of the earnings season is always a good time to take a step back and see who shined (and who not so much). Let’s take a look at how personal care stocks fared in Q3, starting with BeautyHealth (NASDAQ:SKIN).

Wrapping up Q3 earnings, we look at the numbers and key takeaways for the personal care stocks, including e.l.f. (NYSE:ELF) and its peers.

Shares of skincare company BeautyHealth (NASDAQ:SKIN) jumped 18.2% in the morning session after the company reported impressive third-quarter earnings that blew past analysts' EBITDA and EBITDA guidance expectations. Notably, the company turned a profit while Wall Street had predicted a loss. Revenue also beat expectations, though sales declined relative to the previous year. The decline in revenue was primarily due to challenges in system sales, particularly in international markets like China. As a result, the company reduced its full-year sales outlook. To overcome some of the challenges impeding growth, the company revamped its commercial leadership team and appointed a new Chief Revenue Officer and Chief Marketing Officer with more relevant expertise. Also, it provided more flexible pricing for markets affected by high interest rates and limited financing availability​​. 

Skincare company BeautyHealth (NASDAQ:SKIN) announced better-than-expected revenue in Q3 CY2024, but sales fell 19.1% year on year to $78.8 million. On the other hand, the company’s full-year revenue guidance of $327 million at the midpoint came in 4.1% below analysts’ estimates. Its GAAP loss of $0.15 per share was 55.2% below analysts’ consensus estimates.

Skincare company BeautyHealth (NASDAQ:SKIN) will be reporting results tomorrow afternoon. Here’s what you need to know.

As the craze of earnings season draws to a close, here’s a look back at some of the most exciting (and some less so) results from Q2. Today, we are looking at personal care stocks, starting with Coty (NYSE:COTY).

As the Q2 earnings season comes to a close, it’s time to take stock of this quarter’s best and worst performers in the personal care industry, including e.l.f. (NYSE:ELF) and its peers.

As the Q2 earnings season comes to a close, it’s time to take stock of this quarter’s best and worst performers in the personal care industry, including Coty (NYSE:COTY) and its peers.